전남대학교 중앙도서관

Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy.

학술저널

issue: Gynecologic oncology [Gynecol Oncol] 2020 Dec; Vol. 159 (3), pp. 623-629. Date of Electronic Publication: 2020 Oct 05.
Author: Cohen PA; Division of Obstetrics and Gynaecology, University of Western Australia, Crawley, Western Australia, Australia; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia; Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia. Electronic address: paul.cohen@uwa.edu.au.
Leung Y; Division of Obstetrics and Gynaecology, University of Western Australia, Crawley, Western Australia, Australia; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Anderson L; Sydney Medical School, The University of Sydney, New South Wales, Australia; School of Medicine, Western Sydney University, Penrith South, New South Wales, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
van der Griend R; Department of Anatomical Pathology, Canterbury Health Laboratories, Christchurch, New Zealand.
Chivers P; Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
Bilic S; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Bittinger S; Oncology and Dysplasia Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia.
Brand A; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Discipline of Obstetrics and Gynaecology, University of Sydney, Sydney, New South Wales, Australia.
Bulsara MK; Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia.
Codde J; Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Eva L; Dept of Gynaecological Oncology, National Women's Health, Auckland City Hospital, Auckland, New Zealand; Department of Gynaecological Oncology, University of Auckland, Auckland, New Zealand; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Farrell L; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
Harker D; Department of Obstetrics and Gynaecology, Univeristy of Otago, Christchurch, New Zealand.
Herbst U; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Jeffares S; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Loh D; Division of Obstetrics and Gynaecology, University of Western Australia, Crawley, Western Australia, Australia; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
McNally O; Oncology and Dysplasia Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.
Mohan GR; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Nicholson T; Dept of Gynaecological Oncology, National Women's Health, Auckland City Hospital, Auckland, New Zealand.
Powell A; Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Salfinger SG; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Simcock B; Department of Obstetrics and Gynaecology, Univeristy of Otago, Christchurch, New Zealand; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Christchurch Womens Hospital, Christchurch, New Zealand.
Stewart C; Division of Obstetrics and Gynaecology, University of Western Australia, Crawley, Western Australia, Australia; PathWest, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
Silvers J; Oncology and Dysplasia Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia.
Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Sykes P; Department of Obstetrics and Gynaecology, Univeristy of Otago, Christchurch, New Zealand; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Christchurch Womens Hospital, Christchurch, New Zealand.
Stoyles P; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Tan A; Clinipath Pathology, Osborne Park, Western Australia, Australia.
Tan AL; Dept of Gynaecological Oncology, National Women's Health, Auckland City Hospital, Auckland, New Zealand; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
Wrede CDH; Oncology and Dysplasia Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.

학술저널

issue: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2016 Jan; Vol. 26 (1), pp. 133-40.
Author: Black C; The Royal Women's Hospital, Parkville, Victoria, Australia.
Feng A
Bittinger S
Quinn M
Neesham D
McNally O
DB Label: Database : MEDLINE

원문보기: 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택